![John Evans](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Evans
Chief Executive Officer at
BEAM THERAPEUTICS INC.
Net worth: 38 M $ as of 2026-05-30
Profile
Presently, John Evans occupies the position of Chief Executive Officer & Director at Beam Therapeutics, Inc. and Venture Partner at ARCH Venture Partners LLC. Mr. Evans is also on the board of Verve Therapeutics, Inc. He previously occupied the position of Vice President-Business Development & Operations at Agios Pharmaceuticals, Inc. and Investor Relations Contact at Infinity Pharmaceuticals, Inc. Mr. Evans received a graduate degree from the University of Pennsylvania, an undergraduate degree from Yale University and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-31 | 1,150,205 ( 1.12% ) | 38 M $ | 2026-05-30 |
Latest news about John Evans
John Evans active positions
| Companies | Position | Start |
|---|---|---|
| BEAM THERAPEUTICS INC. | Chief Executive Officer | 2016-12-31 |
Blink Therapeutics, Inc.
 Blink Therapeutics, Inc. BiotechnologyHealth Technology Develops novel platform to generate therapeutic and diagnostic monoclonal antibodies | Chief Executive Officer | - |
Orbital Therapeutics, Inc.
 Orbital Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA-based medicines | Director/Board Member | - |
Former positions of John Evans
| Companies | Position | End |
|---|---|---|
| PRIME MEDICINE, INC. | Director/Board Member | 2022-09-12 |
| VERE THER | Director/Board Member | 2022-08-03 |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Private Equity Investor | 2021-03-30 |
| AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2017-03-31 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | 2006-06-30 |
Training of John Evans
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
84
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beam Therapeutics, Inc.
 Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Blink Therapeutics, Inc.
Blink Therapeutics, Inc. BiotechnologyHealth Technology Develops novel platform to generate therapeutic and diagnostic monoclonal antibodies | Health Technology |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
Orbital Therapeutics, Inc.
Orbital Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA-based medicines | Health Technology |
- Stock Market
- Insiders
- John Evans
